HMPL-523 Food Effect and Proton Pump Inhibitor Study
NCT05571787
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsed or Refractory Lymphoma
Interventions
DRUG:
HMPL-523
DRUG:
Rabeprazole
Sponsor
Hutchmed